Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/17/2017 05/18/2017 05/19/2017 05/22/2017 05/23/2017 Date
111.55(c) 108.7(c) 107.75(c) 106.5(c) 105.5 Last
424 453 575 565 634 185 418 745 517 892 Volume
-1.72% -2.55% -0.87% -1.16% -0.94% Change
More quotes
Financials (€)
Sales 2017 15 597 M
EBIT 2017 3 314 M
Net income 2017 1 861 M
Debt 2017 9 708 M
Yield 2017 1,20%
Sales 2018 16 051 M
EBIT 2018 3 559 M
Net income 2018 2 102 M
Debt 2018 7 615 M
Yield 2018 1,30%
P/E ratio 2017 24,49
P/E ratio 2018 20,98
EV / Sales2017 1,50x
EV / Sales2018 1,33x
Capitalization 13 764 M
More Financials
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.It operates through the following segments: Healthcare, Life Science, and Performance Materials.The Healthcare segment comprises of the businesses that were reported separately as the Merck Serono and Consumer Health... 
Sector
Pharmaceuticals
Calendar
06/12 | 03:30pmSpecial Situation
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Latest news on MERCK KGAA
10:24a PFIZER : Merck`s Keytruda nabs I-O`s third bladder cancer approval this month
10:20a ABLYNX : Novel nanobody to start clinical development in osteoarthritis - Ablynx..
05/22 MERCK : ‘It’s not you. It’s your thyroid.’ Campaign Laun..
05/22 MERCK : Acquisition of Merck and Millipore brands.
05/19 MERCK : 100 Healthy Years – Are Kids Prepared?
05/18 MERCK : EpiThany Announces Clinical Collaboration with Merck KGaA, Darmstadt, Ge..
05/18 LIQUID CRYSTALS FOR NEW OPTICAL APPL : Merck Collaborates with the University of..
05/18 MERCK : Continues to Grow Profitably in the First Quarter
05/18DJMERCK : Beats Expectations, Guidance Cautious -- Market Talk
05/18DJMERCK : 1Q Net Profit Falls 12%
More news
Sector news : Specialty & Advanced Pharmaceuticals
11:02a MERCK : UK competition watchdog accuses Merck of obstructing biosimilars
08:35aDJASTRAZENECA : Says Bydureon Trial Meets Safety Objectives; No Significant CV Red..
05/22 Cross-border M&A between U.S. and European firms at 10 year high
05/22DJASTRAZENECA : in Pact with Recordati for Heart-Drug Seloken in Europe
05/19 European shares claw back gains after worst week in six months
More sector news : Specialty & Advanced Pharmaceuticals
4-Traders Strategies on MERCK KGAA 
2016Towards the breakout of a major resistance level
2014Prices move higher as positive news are released
More Strategies
Latest Tweets
11:21aUK competition watchdog accuses Merck of obstructing biosimilars  
11:17aUK competition watchdog accuses Merck of obstructing biosimilars
1
11:11aBRIEF-Merck unit says confident it complied with UK competition law  
11:01aBRIEF-UK's CMA issues statement of objections to Merck's unit  
08:37a[Herald Interview] ‘We think in generations, not in quarters’: Merck chairman..
1
More tweets
Qtime:100
News from SeekingAlpha
05/18 Merck's (MKGAF) on Q1 2017 Results - Earnings Call Transcript
05/18 Merck KGaA reports Q1 results
05/15 Turmoil In Immuno-Oncology
05/10 Tecentriq Failure Puts Accelerated Approval In A Spin
05/10 Physicians Look For Progress In Mesothelioma
Advertisement
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 112 €
Spread / Average Target 4,8%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Stefan Oschmann Chief Executive Officer
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Crocifissa Attardo Member-Supervisory Board
Mechthild Auge Member-Supervisory Board
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA8.67%15 477
ABBVIE INC4.50%104 150
KYOWA HAKKO KIRIN CO L..26.02%10 588
JAZZ PHARMACEUTICALS P..39.38%9 123
CONVATEC GROUP PLC30.83%7 631
ZHANGZHOU PIENTZEHUANG..20.40%4 901
More Results